Grace Therapeutics (GRCE)
NASDAQ:GRCE
Holding GRCE?
Track your performance easily

Grace Therapeutics (GRCE) Technical Analysis

1,140 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Grace Therapeutics’s (GRCE) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Grace Therapeutics is a Buy.
Grace Therapeutics’s (GRCE) 20-Day exponential moving average is 3.17, while Grace Therapeutics’s (GRCE) share price is $3.039, making it a Sell.
Grace Therapeutics’s (GRCE) 50-Day exponential moving average is 3.03, while Grace Therapeutics’s (GRCE) share price is $3.039, making it a Buy.

Grace Therapeutics (GRCE) Pivot Points

Nov 07, 2024, 09:25 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.78
2.87
2.96
3.04
3.13
3.22
3.30
Fibonacci
2.87
2.94
2.98
3.04
3.11
3.15
3.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Grace Therapeutics (GRCE) Moving Averages

Nov 07, 2024, 09:25 AM
Period
Simple
Exponential
MA5
3.10Sell
3.10Sell
MA10
3.18Sell
3.15Sell
MA20
3.27Sell
3.17Sell
MA50
2.94Buy
3.03Buy
MA100
2.86Buy
2.93Buy
MA200
2.94Buy
2.87Buy
Grace Therapeutics’s (GRCE) 10-Day exponential moving average is 3.15, while Grace Therapeutics’s (GRCE) share price is $3.039, making it a Sell.
Grace Therapeutics’s (GRCE) 100-Day exponential moving average is 2.93, while Grace Therapeutics’s (GRCE) share price is $3.039, making it a Buy.
Grace Therapeutics’s (GRCE) stock price is $3.039 and Grace Therapeutics’s (GRCE) 50-day simple moving average is 2.94, creating a Buy signal.
Grace Therapeutics’s (GRCE) stock price is $3.039 and Grace Therapeutics’s (GRCE) 100-day simple moving average is 2.86, creating a Buy signal.
Grace Therapeutics’s (GRCE) stock price is $3.039 and Grace Therapeutics’s (GRCE) 200-day simple moving average is 2.94, creating a Buy signal.

Grace Therapeutics (GRCE) Technical Indicators

Nov 07, 2024, 09:25 AM
Name
Value
Implied Action
RSI (14)
45.96
Neutral
STOCH (9,6)
23.90
Neutral
STOCHRSI (14)
21.77
Neutral
MACD (12,26)
0.02
Buy
ADX (14)
18.44
Buy
Williams %R
-77.78
Buy
CCI (14)
-170.29
Buy
ATR (14)
0.21
-
Ultimate Oscillator
54.31
Neutral
ROC
-7.32
Sell
Grace Therapeutics’s (GRCE) Relative Strength Index (RSI) is 45.96, creating a Neutral signal.
Grace Therapeutics’s (GRCE) Trend Strength Indicator (ADX) is 18.44, creating a Buy signal.
Grace Therapeutics’s (GRCE) Commodity Channel Index (CCI) is -170.29, creating a Buy signal.
Grace Therapeutics’s (GRCE) Price Rate of Change (ROC) is -7.32, creating a Sell signal.

FAQ

Is GRCE a Buy, Hold, or Sell?
Based on GRCE’s technical indicators, GRCE is a Hold.
    What is GRCE’s RSI (14)?
    GRCE’s RSI (14) is 45.96, which suggests GRCE is a Neutral.
      What is GRCE’s MACD?
      GRCE’s MACD is 0.02, which suggests GRCE is a Buy.
        What is GRCE’s 5-day moving average?
        GRCE’s 5-day moving average is 3.10, which suggests GRCE is a Sell.
          What is GRCE’s 20-day moving average?
          GRCE 20-day moving average is 3.27, which suggests GRCE is a Sell.
            What is GRCE’s 50-day moving average?
            GRCE’s 50-day moving average is 2.94, which suggests GRCE is a Buy.
              What is GRCE’s 200-day moving average?
              GRCE’s 200-day moving average is 2.94, which suggests GRCE is a Buy.
                What is GRCE’s Williams % R (14)?
                GRCE’s Williams % R (14) is -77.78, which suggests GRCE is a Buy.
                  What is GRCE’s CCI (14)?
                  GRCE’s CCI (14) is -170.29, which suggests GRCE is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis